Am J Perinatol 2020; 37(06): 589-597
DOI: 10.1055/s-0039-1683897
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Perinatal Outcomes Associated with Early Diabetes Testing in Pregnancies Complicated by Obesity

John F. Mission
1   Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
2   Department of Maternal-Fetal Medicine, Legacy Health System, Portland, Oregon
,
Janet Catov
3   Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
,
Diane Comer
4   Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
,
Kaleab Z. Abebe
4   Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
,
Tiffany E. Deihl
5   Department of Medicine, Ringgold Standard Institution, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Maisa Feghali
5   Department of Medicine, Ringgold Standard Institution, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Christina M. Scifres
6   Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana
› Author Affiliations
Funding This study was funded in part by the Magee-Womens Research Institute, Clinical Research Trainee Award. The funding source was not involved in the study design, collection, analysis, and interpretation of data, in the writing of the report, or the decision to submit the article for publication.
Further Information

Publication History

08 December 2018

18 February 2019

Publication Date:
20 March 2019 (online)

Abstract

Objective This study aimed to determine whether early diabetes testing is associated with differences in perinatal outcomes among pregnant women with obesity (body mass index ≥30 kg/m2).

Study Design We conducted a retrospective cohort study of singleton pregnancies from 2012 to 2014 at a large academic medical center which examined the association of diabetes testing (HBA1c, 50 g glucose challenge test, or 100 g oral glucose tolerance test) before 24 weeks with perinatal outcomes using propensity score modeling and logistic regression.

Results Among women with obesity, 790 out of 2,698 (29.3%) underwent early diabetes testing. Propensity score modeling demonstrated that early testing was associated with higher rates of diabetes diagnosis (odds ratio [OR]: 1.62, 95% confidence interval [CI]: 1.10–2.37, p = 0.01) and a trend toward small for gestational age birth weight (OR: 1.38, 95% CI: 1.00–1.90, p = 0.05) and neonatal composite morbidity (OR: 1.25, 95% CI: 1.00–1.57, p = 0.05) compared with routine testing. Women with inadequate weight gain were more likely a small for gestational age (SGA) infant if they underwent early testing compared with those with routine testing alone (19.8 vs. 11.6%, p = 0.01).

Conclusion Early testing targets higher risk women and yields a higher diabetes diagnosis rate, but inadequate weight gain in these women may increase risk SGA birth weight and neonatal morbidity. Randomized clinical trials are urgently needed to assess whether early diabetes testing improves outcomes in women with obesity.

Note

This work was presented in part at the 37th Annual Pregnancy Meeting, the Society for Maternal-Fetal Medicine, Las Vegas, NV, January 23–28, 2017.


 
  • References

  • 1 Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA 2016; 315 (21) 2284-2291
  • 2 Alanis MC, Goodnight WH, Hill EG, Robinson CJ, Villers MS, Johnson DD. Maternal super-obesity (body mass index > or = 50) and adverse pregnancy outcomes. Acta Obstet Gynecol Scand 2010; 89 (07) 924-930
  • 3 Torloni MR, Betrán AP, Horta BL. , et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009; 10 (02) 194-203
  • 4 Weiss JL, Malone FD, Emig D. , et al; FASTER Research Consortium. Obesity, obstetric complications and cesarean delivery rate--a population-based screening study. Am J Obstet Gynecol 2004; 190 (04) 1091-1097
  • 5 Sebire NJ, Jolly M, Harris JP. , et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25 (08) 1175-1182
  • 6 Ovesen P, Rasmussen S, Kesmodel U. Effect of prepregnancy maternal overweight and obesity on pregnancy outcome. Obstet Gynecol 2011; 118 (2 Pt 1): 305-312
  • 7 Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; 191 (03) 964-968
  • 8 Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction 2010; 140 (03) 365-371
  • 9 Harmon KA, Gerard L, Jensen DR. , et al. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth. Diabetes Care 2011; 34 (10) 2198-2204
  • 10 Selvin E, Wang D, Lee AK, Bergenstal RM, Coresh J. Identifying trends in undiagnosed diabetes in U.S. adults by using a confirmatory definition: a cross-sectional study. Ann Intern Med 2017; 167 (11) 769-776
  • 11 Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
  • 12 American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41 (Suppl. 01) S13-S27
  • 13 Blumer I, Hadar E, Hadden DR. , et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013; 98 (11) 4227-4249
  • 14 Mission JF, Catov J, Deihl TE, Feghali M, Scifres C. Early pregnancy diabetes screening and diagnosis: prevalence, rates of abnormal test results, and associated factors. Obstet Gynecol 2017; 130 (05) 1136-1142
  • 15 Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. ; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352 (24) 2477-2486
  • 16 Landon MB, Spong CY, Thom E. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361 (14) 1339-1348
  • 17 Moyer VA. Force USPST; U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160 (06) 414-420
  • 18 Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144 (07) 768-773
  • 19 Standards of medical care in diabetes-2017: summary of revisions. Diabetes Care 2017; 40 (Suppl. 01) S4-S5
  • 20 Institute of Medicine, National Research Council Committee to Reexamine IOMPWG. The National Academies Collection: reports funded by National Institutes of Health. In: Rasmussen KM, Yaktine AL. , eds. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press (US) National Academy of Sciences; 2009
  • 21 Scifres CM, Feghali MN, Althouse AD, Caritis SN, Catov JM. Effect of excess gestational weight gain on pregnancy outcomes in women with type 1 diabetes. Obstet Gynecol 2014; 123 (06) 1295-1302
  • 22 Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87 (02) 163-168
  • 23 Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 2015; 34 (28) 3661-3679
  • 24 Rosenbaum PR, Rubin DB. . The central role of propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55
  • 25 Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 2009; 32 (09) 1639-1643
  • 26 Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG 2006; 113 (10) 1126-1133
  • 27 Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005; 28 (02) 323-328
  • 28 Scifres C, Feghali M, Althouse AD, Caritis S, Catov J. Adverse outcomes and potential targets for intervention in gestational diabetes and obesity. Obstet Gynecol 2015; 126 (02) 316-325
  • 29 Sovio U, Murphy HR, Smith GC. Accelerated fetal growth prior to diagnosis of gestational diabetes mellitus: a prospective cohort study of nulliparous women. Diabetes Care 2016; 39 (06) 982-987
  • 30 Vesco KK, Karanja N, King JC. , et al. Efficacy of a group-based dietary intervention for limiting gestational weight gain among obese women: a randomized trial. Obesity (Silver Spring) 2014; 22 (09) 1989-1996
  • 31 Rowan JA, Budden A, Ivanova V, Hughes RC, Sadler LC. Women with an HbA1c of 41-49 mmol/mol (5.9-6.6%): a higher risk subgroup that may benefit from early pregnancy intervention. Diabet Med 2016; 33 (01) 25-31
  • 32 Hughes RC, Moore MP, Gullam JE, Mohamed K, Rowan J. An early pregnancy HbA1c >/=5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care 2014; 37 (11) 2953-2959
  • 33 Johnson J, Clifton RG, Roberts JM. , et al; Eunice Kennedy Shriver National Institute of Child Health; Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines. Obstet Gynecol 2013; 121 (05) 969-975
  • 34 Bodnar LM, Siega-Riz AM, Simhan HN, Himes KP, Abrams B. Severe obesity, gestational weight gain, and adverse birth outcomes. Am J Clin Nutr 2010; 91 (06) 1642-1648
  • 35 Vesco KK, Sharma AJ, Dietz PM. , et al. Newborn size among obese women with weight gain outside the 2009 Institute of Medicine recommendation. Obstet Gynecol 2011; 117 (04) 812-818
  • 36 Catalano PM, Mele L, Landon MB. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Inadequate weight gain in overweight and obese pregnant women: what is the effect on fetal growth?. Am J Obstet Gynecol 2014; 211 (02) 137.e1-137.e7
  • 37 Dalfrà MG, Pacini G, Parretti E, Ragazzi E, Mello G, Lapolla A. Elevated insulin sensitivity and β-cell function during pregnancy in mothers of growth-restricted newborns. Am J Physiol Endocrinol Metab 2011; 301 (01) E25-E30
  • 38 Melamed N, Hiersch L, Peled Y, Hod M, Wiznitzer A, Yogev Y. The association between low 50 g glucose challenge test result and fetal growth restriction. J Matern Fetal Neonatal Med 2013; 26 (11) 1107-1111
  • 39 Mello G, Elena P, Ognibene A. , et al. Lack of concordance between the 75-g and 100-g glucose load tests for the diagnosis of gestational diabetes mellitus. Clin Chem 2006; 52 (09) 1679-1684
  • 40 Bangalore S, Bhatt DL, Röther J. , et al; REACH Registry Investigators. Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation 2010; 122 (11) 1091-1100